Trial · NCT00927862
Results by group18
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 18 of 18
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| The Percent of Out of Range (OOR) International Normalized Prothrombin Time Ratio (INRs) in the Standard and Modified Pharmacogenetic Arms. | Standard IWPC Warfarin Dosing Algorithm | 30.6 | 95% Confidence Interval 27.6 to 33.7 | percent | |
| The Percent of Out of Range (OOR) International Normalized Prothrombin Time Ratio (INRs) in the Standard and Modified Pharmacogenetic Arms. | Modified IWPC Warfarin Dosing Algorithm | 31.8 | 95% Confidence Interval 28.8 to 34.8 | percent | |
| The Percent of INRs ≥4 or ≤1.5 for the Modified IWPC Warfarin Algorithm and the Standard IWPC Warfarin Algorithm | Standard IWPC Warfarin Dosing Algorithm | 15.2 | Standard Deviation 20.5 | percent | |
| The Percent of INRs ≥4 or ≤1.5 for the Modified IWPC Warfarin Algorithm and the Standard IWPC Warfarin Algorithm | Modified IWPC Warfarin Dosing Algorithm | 15.4 | Standard Deviation 18.2 | percent | |
| The Percent of INRs ≥4 or ≤1.5 or SAEs Among the Modified IWPC Warfarin Algorithm and Standard IWPC Warfarin Algorithm. | Standard IWPC Warfarin Dosing Algorithm | 53.6 | percent | ||
| The Percent of INRs ≥4 or ≤1.5 or SAEs Among the Modified IWPC Warfarin Algorithm and Standard IWPC Warfarin Algorithm. | Modified IWPC Warfarin Dosing Algorithm | 59.2 | percent | ||
| The Number of INRs Measured up to 3 Months in the Pharmacogenetic (PG) (Modified and Standard) Algorithms and Parallel Controls. | PG Dosing Patients | 7.70 | Standard Deviation 3.99 | INRs | |
| The Number of INRs Measured up to 3 Months in the Pharmacogenetic (PG) (Modified and Standard) Algorithms and Parallel Controls. | Parallel Controls | 7.47 | Standard Deviation 7.27 | INRs | |
| Prediction of a Stable Maintenance Dose Among the Pharmacogenetic (PG)-Guided Dosing Algorithms and the Parallel Controls | PG Dosing Patients | 63.2 | percent | ||
| Prediction of a Stable Maintenance Dose Among the Pharmacogenetic (PG)-Guided Dosing Algorithms and the Parallel Controls | Parallel Controls | 37.6 | percent | ||
| The Percent of Out of Range (OOR) INRs in Pharmacogenetic-guided Patients and Parallel Controls | PG Dosing Patients | 31.2 | 95% Confidence Interval 29.2 to 33.5 | percent | |
| The Percent of Out of Range (OOR) INRs in Pharmacogenetic-guided Patients and Parallel Controls | Parallel Controls | 41.5 | 95% Confidence Interval 39.9 to 43.2 | percent | |
| The Percent of Time in Therapeutic Range (TTR) for the Standard and Modified Pharmacogenetic Algorithms. | Standard IWPC Warfarin Dosing Algorithm | 70.2 | 95% Confidence Interval 67.2 to 73.3 | percent | |
| The Percent of Time in Therapeutic Range (TTR) for the Standard and Modified Pharmacogenetic Algorithms. | Modified IWPC Warfarin Dosing Algorithm | 67.5 | 95% Confidence Interval 64.5 to 70.6 | percent | |
| The Time in Therapeutic Range (TTR) for the Pharmacogenetic-guided Patients and Parallel Controls | PG Dosing Patients | 68.9 | 95% Confidence Interval 67.2 to 70.6 | percent | |
| The Time in Therapeutic Range (TTR) for the Pharmacogenetic-guided Patients and Parallel Controls | Parallel Controls | 58.4 | 95% Confidence Interval 56.8 to 60.0 | percent | |
| The Percent of INRs ≥4 or ≤1.5 in the Pharmacogenetic (PG)-Guided Dosing Arms and the Parallel Control Arm | PG Dosing Patients | 15.3 | Standard Deviation 19.4 | percent | |
| The Percent of INRs ≥4 or ≤1.5 in the Pharmacogenetic (PG)-Guided Dosing Arms and the Parallel Control Arm | Parallel Controls | 27.4 | Standard Deviation 32.5 | percent |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00927862/results